Alarar Capital Group is pleased to announce its role as the financial advisor to Gelteq Limited (“Gelteq”), a pioneering biotechnology firm, in its initial public (IPO) offering on Nasdaq. Gelteq has priced its IPO of 1,300,000 ordinary shares at US$4.00 per share, yielding gross proceeds of US $5.2 million. Trading commenced yesterday on Nasdaq on October 29, 2024, under the ticker symbol “GELS.”

About Gelteq Limited

Gelteq, based in Melbourne, Australia, specializes in the development of ingestible gel technology designed to improve the delivery of nutrients and pharmaceuticals. The funds raised will support the Company’s continued investment in manufacturing, marketing, and R&D initiatives aimed at advancing its innovative gel-based delivery solutions across key industries, including pharmaceuticals, nutraceuticals as well as animal health.

“This IPO marks an exciting milestone for Gelteq as it enters the global public markets. It has been an honor to work alongside Gelteq’s team, and we are thrilled to have supported them in reaching this significant achievement,” said Jesús Hoyos, Managing Partner at Alarar Capital Group. “Gelteq’s platform has the potential to revolutionize drug delivery systems, and we look forward to seeing the Company’s continued success as it scales.”

Alarar Capital Group is proud to have served as Gelteq’s financial advisor in this transaction.

Jesús Hoyos, Managing Partner at Alarar Capital Group, added, “This transaction highlights the value Alarar Capital Group brings to emerging growth companies seeking access to international capital markets. Gelteq is at the forefront of its field, and we are proud to have been part of their journey to Nasdaq.”

About Alarar Capital Group

Alarar Capital Group is a globally based, full-service financial institution, specializing in bridging Asia and the West. Our services encompass a full spectrum of financial solutions, including IPOs, M&A, financing, venture capital, and SPACs. Alarar Capital Group also includes an independent consulting division dedicated to addressing the unique challenges faced by companies operating across both Asian and Western markets. Headquartered in Hong Kong, with offices across Mainland China, the USA, Malaysia, Indonesia, Vietnam, India, Sweden, and the UAE, we are well-positioned to provide cross-border financial and advisory services.

Our commitment to anticipating market trends and delivering client-centered solutions has earned Alarar Capital Group the Frost & Sullivan 2024 Company of the Year Award in the Asian mid-market investment advisory sector.

For more information or any questions, please contact:

Jesús Hoyos
Managing Partner
[email protected]

For media inquiries, please contact:

Anna Sahlberg Carlsson
Marketing Manager
[email protected]